Skip to main content
Clinical Trials/CTRI/2009/091/000309
CTRI/2009/091/000309
Completed
Phase 3

A RANDOMIZED CONTROLLED CLINICAL TRIAL TO COMPARE THE SAFETY AND EFFICACY OF EDARAVONE IN ACUTE ISCHEMIC STROKE

ONE0 sites52 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
ONE
Enrollment
52
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ONE

Eligibility Criteria

Inclusion Criteria

  • Patients with acute ischemic stroke hospitalized between 6 and 72 hours of onset of stroke.

Exclusion Criteria

  • Patients with age less than 18 years, unclear time of onset, those who received any thrombolytic therapy, those with severe hepatic disease, renal dysfunction, pregnancy or lactating female.

Outcomes

Primary Outcomes

Not specified

Similar Trials